Literature DB >> 28632005

Sleep Problems and Life Satisfaction as Predictors of Health in Men with Sex Chromosome Aneuploidies.

Krister W Fjermestad1, Simen Stokke2.   

Abstract

More knowledge is needed about men with sex chromosome aneuploidies (SCA). We present self-reported data from 53 men with SCA (Mage = 36.8 years, SD = 12.3, range 19-67). The Health Survey-Short Form (SF-36) measured eight health domains (physical functioning, role-physical, role-emotional, vitality, emotional health, social functioning, pain, general health). The Pittsburgh Sleep Quality Index measured sleep problems. The Personal Wellbeing Index measured satisfaction with eight life domains. Compared to norms, SCA reported poorer health (mean d = -0.80) and more sleep problems (mean d = -0.85). Differences between SCA and norms on personal well-being were small, except lower health satisfaction in SCA (d = -1.06). Seven of eight regression models predicting the SF-36 domains from life satisfaction and sleep problems were significant (explained variance 12.2% to 46.2%), except physical functioning (ns). Clinical assessment/intervention for a broad range of health and sleep problems is indicated for men with SCA.

Entities:  

Keywords:  47XXY; 47XYY; Klinefelter syndrome; male health; sex chromosome aneuploidy

Mesh:

Year:  2017        PMID: 28632005     DOI: 10.1080/08964289.2017.1282852

Source DB:  PubMed          Journal:  Behav Med        ISSN: 0896-4289            Impact factor:   3.104


  2 in total

Review 1.  Morbidity in Klinefelter syndrome and the effect of testosterone treatment.

Authors:  Simon Chang; Anne Skakkebaek; Shanlee M Davis; Claus H Gravholt
Journal:  Am J Med Genet C Semin Med Genet       Date:  2020-06-04       Impact factor: 3.908

2.  The Lived Experience of Klinefelter Syndrome: A Narrative Review of the Literature.

Authors:  Esmée Sinéad Hanna; Tim Cheetham; Kristine Fearon; Cathy Herbrand; Nicky Hudson; Kevin McEleny; Richard Quinton; Eleanor Stevenson; Scott Wilkes
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-26       Impact factor: 5.555

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.